Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Initial Experience with a Flow Redirection Endoluminal Device Stent-A Brazilian Multicenter Study.

Manzato LB, Santos RB, Teixeira DO, Mesquita Filho PM, Azambuja ND Jr, Frighetto L, Vanzin JR.

J Stroke Cerebrovasc Dis. 2018 Aug;27(8):e158-e164. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.057. Epub 2018 Mar 30. No abstract available.

PMID:
29610040
2.

Petroclival meningiomas: Remaining controversies in light of minimally invasive approaches.

Wayhs SY, Lepski GA, Frighetto L, Isolan GR.

Clin Neurol Neurosurg. 2017 Jan;152:68-75. doi: 10.1016/j.clineuro.2016.11.021. Epub 2016 Nov 29. Review.

PMID:
27915104
3.

Stereotactic radiosurgery for movement disorders.

Frighetto L, Bizzi J, Annes RD, Silva Rdos S, Oppitz P.

Surg Neurol Int. 2012;3(Suppl 1):S10-6. doi: 10.4103/2152-7806.91605. Epub 2012 Jan 14.

4.

Köhlmeier-Degos Disease (malignant atrophic papulosis) and neurologic involvement.

Slaviero F, Annes RD, Frighetto L, Schirmer LM, Vanzin JR, Fröhlich AC, Ferraz J, Azambuja ND Jr.

Arq Neuropsiquiatr. 2009 Sep;67(3A):692-4. No abstract available.

5.

Best possible medication history by a pharmacy technician at a tertiary care hospital.

Remtulla S, Brown G, Frighetto L.

Can J Hosp Pharm. 2009 Sep;62(5):402-5. No abstract available.

6.

Middle cranial fossa arachnoid cysts complicated with subdural collections.

Slaviero F, Frighetto L, Azambuja Júnior ND, Martins LS, Annes RD, Vanzin JR.

Arq Neuropsiquiatr. 2008 Dec;66(4):913-5. No abstract available.

7.

Primary central nervous system lymphoma in an immunocompetent host.

Slaviero F, Frighetto L, Casali Júnior J, Santos MN, Vanzin JR, Azambuja ND Jr.

Arq Neuropsiquiatr. 2008 Sep;66(3A):542-4. No abstract available.

8.

Modulation of food intake following deep brain stimulation of the ventromedial hypothalamus in the vervet monkey. Laboratory investigation.

Laćan G, De Salles AA, Gorgulho AA, Krahl SE, Frighetto L, Behnke EJ, Melega WP.

J Neurosurg. 2008 Feb;108(2):336-42. doi: 10.3171/JNS/2008/108/2/0336.

PMID:
18240931
9.

Increased fast ripple to ripple ratios correlate with reduced hippocampal volumes and neuron loss in temporal lobe epilepsy patients.

Staba RJ, Frighetto L, Behnke EJ, Mathern GW, Fields T, Bragin A, Ogren J, Fried I, Wilson CL, Engel J Jr.

Epilepsia. 2007 Nov;48(11):2130-8. Epub 2007 Jul 28.

10.

Willingness to pay to assess patient preferences for therapy in a Canadian setting.

Marra CA, Frighetto L, Goodfellow AF, Wai AO, Chase ML, Nicol RE, Leong CA, Tomlinson S, Ferreira BM, Jewesson PJ.

BMC Health Serv Res. 2005 Jun 7;5:43.

11.
12.

Deep brain stimulation in intraoperative MRI environment - comparison of imaging techniques and electrode fixation methods.

Lee MW, De Salles AA, Frighetto L, Torres R, Behnke E, Bronstein JM.

Minim Invasive Neurosurg. 2005 Feb;48(1):1-6.

PMID:
15747209
13.

Radiosurgery and stereotactic radiotherapy for intracranial meningiomas.

Torres RC, Frighetto L, De Salles AA, Goss B, Medin P, Solberg T, Ford JM, Selch M.

Neurosurg Focus. 2003 May 15;14(5):e5.

PMID:
15669816
14.

Functional neurosurgery in the MRI environment.

De Salles AA, Frighetto L, Behnke E, Sinha S, Tseng L, Torres R, Lee M, Cabatan-Awang C, Frysinger R.

Minim Invasive Neurosurg. 2004 Oct;47(5):284-9.

PMID:
15578341
15.

Novalis Shaped Beam Radiosurgery of arteriovenous malformations.

Pedroso AG, De Salles AA, Tajik K, Golish R, Smith Z, Frighetto L, Solberg T, Cabatan-Awang C, Selch MT.

J Neurosurg. 2004 Nov;101 Suppl 3:425-34.

PMID:
15537200
16.

Linear accelerator thalamotomy.

Frighetto L, De Salles A, Wallace R, Ford J, Selch M, Cabatan-Awang C, Solberg T.

Surg Neurol. 2004 Aug;62(2):106-13; discussion 113-4.

PMID:
15261496
17.

Stereotactic radiotherapy for treatment of cavernous sinus meningiomas.

Selch MT, Ahn E, Laskari A, Lee SP, Agazaryan N, Solberg TD, Cabatan-Awang C, Frighetto L, Desalles AA.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):101-11.

PMID:
15093905
18.

An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients.

Frighetto L, Marra C, Bandali S, Wilbur K, Naumann T, Jewesson P.

Health Qual Life Outcomes. 2004 Mar 24;2:17.

19.

Noninvasive linear accelerator radiosurgery as the primary treatment for trigeminal neuralgia.

Frighetto L, De Salles AA, Smith ZA, Goss B, Selch M, Solberg T.

Neurology. 2004 Feb 24;62(4):660-2.

PMID:
14981193
20.

Radiosurgery can achieve precision needed for functional neurosurgery.

De Salles AA, Frighetto L, Lacan G, Melega W.

Arch Neurol. 2003 Oct;60(10):1494-6; author reply 1496. No abstract available.

PMID:
14568828
21.

Linear accelerator radiosurgery using 90 gray for essential trigeminal neuralgia: results and dose volume histogram analysis.

Goss BW, Frighetto L, DeSalles AA, Smith Z, Solberg T, Selch M.

Neurosurgery. 2003 Oct;53(4):823-8; discussion 828-30.

PMID:
14519214
22.

Stereotactic radiotherapy for the treatment of lymphocytic hypophysitis. Report of two cases.

Selch MT, DeSalles AA, Kelly DF, Frighetto L, Vinters HV, Cabatan-Awang C, Wallace RE, Solberg TD.

J Neurosurg. 2003 Sep;99(3):591-6.

PMID:
12959451
23.

Dedicated linear accelerator radiosurgery for the treatment of trigeminal neuralgia.

Smith ZA, De Salles AA, Frighetto L, Goss B, Lee SP, Selch M, Wallace RE, Cabatan-Awang C, Solberg T.

J Neurosurg. 2003 Sep;99(3):511-6.

PMID:
12959439
24.

Stereotactic and microsurgery for acoustic neuroma: the controversy continues.

De Salles AA, Frighetto L, Selch M.

Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1215-7. No abstract available.

PMID:
12873663
25.

Image-guided frameless stereotactic biopsy sampling of parasellar lesions. Technical note.

Frighetto L, De Salles AA, Behnke E, Smith ZA, Chute D.

J Neurosurg. 2003 Apr;98(4):920-5.

PMID:
12691424
26.

Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy.

Chitapanarux I, Goss B, Vongtama R, Frighetto L, De Salles A, Selch M, Duick M, Solberg T, Wallace R, Cabatan-Awang C, Ford J.

J Neurooncol. 2003 Jan;61(2):143-9.

PMID:
12622453
27.
28.

Quality-of-life assessment in an outpatient parenteral antibiotic program.

Goodfellow AF, Wai AO, Frighetto L, Marra CA, Ferreira BM, Chase ML, Nicol RE, Leong CA, Tomlinson S, Jewesson PJ.

Ann Pharmacother. 2002 Dec;36(12):1851-5.

PMID:
12452743
29.

Radiosurgery and stereotactic radiation therapy of skull base meningiomas: proposal of a grading system.

De Salles AA, Frighetto L, Grande CV, Solberg TD, Cabatan-Awang C, Selch MT, Wallace R, Ford J.

Stereotact Funct Neurosurg. 2001;76(3-4):218-29.

PMID:
12378101
30.

Influence of standardized orders on postoperative nausea and vomiting after gynecologic surgery.

St Pierre E, Frighetto L, Marra CA.

Ann Pharmacother. 2002 Feb;36(2):210-7.

PMID:
11847936
31.

Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective.

Sinclair SE, Frighetto L, Loewen PS, Sunderji R, Teal P, Fagan SC, Marra CA.

Pharmacoeconomics. 2001;19(9):927-36.

PMID:
11700779
32.
33.

Influence of the British Columbia reference drug program on hospital formularies: a survey of hospital pharmacy managers.

Gill NJ, Frighetto L, Marra C, Jewesson P.

Can J Clin Pharmacol. 2000 Summer;7(2):109-14.

PMID:
10958707
34.

A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis.

Marra CA, Frighetto L, Quaia CB, de Lemos ML, Warkentin DI, Marra F, Jewesson PJ.

Pharmacotherapy. 2000 Aug;20(8):931-40.

PMID:
10939554
35.

Economic impact of standardized orders for antimicrobial prophylaxis program.

Frighetto L, Marra CA, Stiver HG, Bryce EA, Jewesson PJ.

Ann Pharmacother. 2000 Feb;34(2):154-60.

PMID:
10676821
36.

Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes. A Canadian hospital perspective.

Balen RM, Marra CA, Zed PJ, Cohen M, Frighetto L.

Pharmacoeconomics. 1999 Nov;16(5 Pt 2):533-42.

PMID:
10662478
37.

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin.

Yoshida EM, Erb SR, Partovi N, Scudamore CH, Chung SW, Frighetto L, Eggen HJ, Steinbrecher UP.

Liver Transpl Surg. 1999 Nov;5(6):520-5.

38.
39.

Experience with ceftazidime parenteral-to-parenteral dosage stepdown in the empiric treatment of febrile neutropenia.

Schwagly N, Frighetto L, MacDougall C, Jewesson P.

Pharmacotherapy. 1999 May;19(5):641-7.

PMID:
10331828
40.

Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective.

Marra FO, Frighetto LO, Marra CA, Sleigh KM, Stiver HG, Bryce EA, Reynolds RP, Jewesson PJ.

Ann Pharmacother. 1999 Feb;33(2):156-62.

PMID:
10084409
41.

Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital.

Marra F, Reynolds R, Stiver G, Bryce E, Sleigh K, Frighetto L, MacDougall C, Jewesson P.

Diagn Microbiol Infect Dis. 1998 Jun;31(2):355-68.

PMID:
9635910
42.

Cost-effectiveness analysis of abciximab: a Canadian hospital perspective.

Zed PJ, Frighetto L, Sunderji R, Marra CA.

Ann Pharmacother. 1998 May;32(5):536-42. Erratum in: Ann Pharmacother 1998 Jul-Aug;32(7-8):845.

PMID:
9606473
43.

A double-blind, randomized study of three antimicrobial regimens in the prevention of infections after elective colorectal surgery.

Jewesson P, Chow A, Wai A, Frighetto L, Nickoloff D, Smith J, Schwartz L, Sleigh K, Danforth D, Pezim M, Stoller J, Stiver G.

Diagn Microbiol Infect Dis. 1997 Nov;29(3):155-65.

PMID:
9401808
44.

Tracking and reporting drug expenditures.

Frighetto L, Marra CA, Jewesson PJ.

Am J Health Syst Pharm. 1997 Oct 15;54(20):2302, 2305-6. No abstract available.

PMID:
9347103
45.

Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous-oral stepdown program.

Malfair SC, Frighetto L, Nickoloff DM, Martinusen SM, Jewesson PJ.

Ann Pharmacother. 1996 Apr;30(4):337-42.

PMID:
8729884
46.

Double-blind comparison of cefazolin and ceftizoxime for prophylaxis against infections following elective biliary tract surgery.

Jewesson PJ, Stiver G, Wai A, Frighetto L, Nickoloff D, Smith J, Schwartz L, Sleigh K, Danforth D, Scudamore C, Chow A.

Antimicrob Agents Chemother. 1996 Jan;40(1):70-4.

47.

Aprotinin reduces the need for blood products during liver transplantation.

Scudamore CH, Randall TE, Jewesson PJ, Shackleton CR, Salvian AJ, Fagan M, Frighetto L, Growe GH, Scarth I, Erb SR.

Am J Surg. 1995 May;169(5):546-9.

PMID:
7538269
48.

Ciprofloxacin use under a reserved drug and stepdown promotion program.

Frighetto L, Martinusen SM, Mamdani F, Jewesson PJ.

Can J Hosp Pharm. 1995 Feb;48(1):35-42.

PMID:
10141061
49.

Antibiotic therapeutic interchange program: six years of experience.

Frighetto L, Nickoloff D, Jewesson P.

Hosp Formul. 1995 Feb;30(2):92-3, 97-8, 100 passim.

PMID:
10140352
50.

Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit.

Rayani SA, Nimmo CJ, Frighetto L, Martinusen SM, Nickoloff DM, Reece DE, Jewesson PJ.

Ann Pharmacother. 1994 Jul-Aug;28(7-8):852-6.

PMID:
7949499

Supplemental Content

Loading ...
Support Center